Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer. Reply. Heymach JV, Harpole D, Reck M. N Engl J Med 2024;390:287-288.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Heymach JV, Harpole D, Reck M. Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer. Reply. N Engl J Med 2024;390:287-288.
PMID: 38231635